David Chisnall discusses how the CHERI hardware architecture redefines pointer safety to solve isolation and sharing challenges. He explains how CHERI enables spatial and temporal memory safety for ...
The US Food and Drug Administration (FDA) has updated its seven-year-old guidance to clarify the differences among abbreviated approval pathways and the data it will accept for these applications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results